Welcome to the patients and public area of the MHRA website. This section provides targeted links to information throughout the site which is aimed specifically at patients and the public.
The section includes latest news and hot topics for the MHRA, details on reporting safety problems and information on specific medicines, devices and conditions.
If you have any feedback on this section and how we can improve it please email email@example.com or fill out our feedback form.
News and hot topics
16 Oct 2014 | EMA public consultation on functional specification for portal and database that will underpin the EU Clinical Trials Regulation (deadline 31 October 2014)
EMA have launched a public consultation on the functional specification for a portal and database that will underpin the EU Clinical Trials Regulation. Stakeholders are invited to review the document and provide comments to the EMA by 31 October 2014.
This MDA has been issued to further encourage healthcare professionals to report cases of anaplastic large cell lymphoma (ALCL) in women who have breast implants or who have had them removed.
17 Jun 2014 | New EU Clinical Trials Regulation published
On 27 May 2014, the Clinical Trials Regulation was published in the Official Journal of the EU (OJEU).
29 May 2014 | Medical Device Alert: Paradigm ambulatory insulin infusion pumps manufactured by Medtronic (MDA/2014/019)
This MDA is being issued due to risk of hypoglycaemia due to incorrect selection and delivery of bolus amount.
28 Apr 2014 | Company-led drug recall: Herceptin 150 mg powder for concentrate for solution for infusion - Roche Products Limited - CLDA (14)A06
Further to CLDA (14)A05, Roche Products Limited is expanding the recall to wholesale level in the UK to include all batches Herceptin 150 mg powder for concentrate for solution for infusion labelled as Italian Herceptin® 150 mg.
Contacting the MHRA
Medicines, devices and conditions
My medicine: From laboratory to pharmacy shelf
Reporting safety problems
It is crucial that issues with medicines and medical devices are reported to the MHRA, as this allows us to monitor the safety and efficacy of products, and take action if necessary. This page provides links to information about reporting problems with medicines, vaccines and devices.
Buying counterfeit medicines and medicines online
Counterfeit medicines and medicines bought online are an increasing problem, both in the UK and globally. This page provides links to information about the risks of buying medicines over the internet and counterfeit medicines and devices.
Herbal and homeopathic medicines
Herbal and homeopathic medicines and substance are medicines in their own right. As with any other medicine they are likely to have an effect on the body and should be used with care.